108 related articles for article (PubMed ID: 30217447)
21. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.
Walk SF; March ME; Ravichandran KS
Eur J Immunol; 1998 Aug; 28(8):2265-75. PubMed ID: 9710204
[TBL] [Abstract][Full Text] [Related]
22. Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton's tyrosine kinase (BTK) signaling.
Hsu J; Zhang J; Kitson C; Tan SL; Narula S; DeMartino JA; Liao C
J Biomol Screen; 2013 Sep; 18(8):890-8. PubMed ID: 23704133
[TBL] [Abstract][Full Text] [Related]
23. STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.
Uckun FM; Qazi S; Ma H; Tuel-Ahlgren L; Ozer Z
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2902-7. PubMed ID: 20133729
[TBL] [Abstract][Full Text] [Related]
24. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat.
Tanaka N; Abe H; Yagita H; Okumura K; Nakamura M; Sugamura K
Eur J Immunol; 1997 Apr; 27(4):834-41. PubMed ID: 9130632
[TBL] [Abstract][Full Text] [Related]
25. Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells.
Taler M; Shpungin S; Salem Y; Malovani H; Pasder O; Nir U
Mol Endocrinol; 2003 Aug; 17(8):1580-92. PubMed ID: 12738762
[TBL] [Abstract][Full Text] [Related]
26. Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.
Mamand S; Allchin RL; Ahearne MJ; Wagner SD
Sci Rep; 2018 Sep; 8(1):14216. PubMed ID: 30242208
[TBL] [Abstract][Full Text] [Related]
27. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
[TBL] [Abstract][Full Text] [Related]
28. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
Zeng KW; Wang S; Dong X; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2014 Mar; 275(3):244-56. PubMed ID: 24486434
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.
Sacristán C; Schattgen SA; Berg LJ; Bunnell SC; Roy AL; Rosenstein Y
Eur J Immunol; 2009 Sep; 39(9):2584-95. PubMed ID: 19701889
[TBL] [Abstract][Full Text] [Related]
30. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation.
Hosoya N; Qiao Y; Hangaishi A; Wang L; Nannya Y; Sanada M; Kurokawa M; Chiba S; Hirai H; Ogawa S
Genes Chromosomes Cancer; 2005 Mar; 42(3):269-79. PubMed ID: 15611931
[TBL] [Abstract][Full Text] [Related]
31. SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK.
Bogin Y; Ainey C; Beach D; Yablonski D
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6638-43. PubMed ID: 17420479
[TBL] [Abstract][Full Text] [Related]
32. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
Marengère LE; Okkenhaug K; Clavreul A; Couez D; Gibson S; Mills GB; Mak TW; Rottapel R
J Immunol; 1997 Oct; 159(7):3220-9. PubMed ID: 9317120
[TBL] [Abstract][Full Text] [Related]
33. Keeping the (kinase) party going: SLP-76 and ITK dance to the beat.
Qi Q; August A
Sci STKE; 2007 Jul; 2007(396):pe39. PubMed ID: 17652306
[TBL] [Abstract][Full Text] [Related]
34. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
35. The Syk protein tyrosine kinase can function independently of CD45 or Lck in T cell antigen receptor signaling.
Chu DH; Spits H; Peyron JF; Rowley RB; Bolen JB; Weiss A
EMBO J; 1996 Nov; 15(22):6251-61. PubMed ID: 8947048
[TBL] [Abstract][Full Text] [Related]
36. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
Pao LI; Cambier JC
J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
[TBL] [Abstract][Full Text] [Related]
37. Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3.
Kasprzycka M; Marzec M; Liu X; Zhang Q; Wasik MA
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9964-9. PubMed ID: 16766651
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock.
Gyurkovska V; Ivanovska N
Eur J Pharmacol; 2015 Mar; 751():118-26. PubMed ID: 25666385
[TBL] [Abstract][Full Text] [Related]
39. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
40. FER kinase activation of Stat3 is determined by the N-terminal sequence.
Priel-Halachmi S; Ben-Dor I; Shpungin S; Tennenbaum T; Molavani H; Bachrach M; Salzberg S; Nir U
J Biol Chem; 2000 Sep; 275(37):28902-10. PubMed ID: 10878010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
